Kynam Capital Management, LP Sutro Biopharma, Inc. Transaction History
Kynam Capital Management, LP
- $1.58 Billion
- Q4 2024
A detailed history of Kynam Capital Management, LP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 3,641,447 shares of STRO stock, worth $3.28 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
3,641,447
Previous 2,066,447
76.22%
Holding current value
$3.28 Million
Previous $7.15 Million
6.28%
% of portfolio
0.42%
Previous 0.59%
Shares
8 transactions
Others Institutions Holding STRO
# of Institutions
128Shares Held
59.9MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$6.72 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$6.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$3.79 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$2.31 Million0.28% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.46MShares$2.21 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $46.9M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...